James Paget University Hospital is at Gorleston-on-Sea, Great Yarmouth, Norfolk, England, on the A47 Lowestoft Road. It is managed by the James Paget University Hospitals NHS Foundation Trust.

During the past decade, James Paget University Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James Paget University Hospital" #1 sponsor was "Aimmune Therapeutics, Inc." with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James Paget University Hospital" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Action Medical Research" with 1 trials as a collaborator, "Applied Health Research Centre" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "James Paget University Hospital" are "Breast Cancer" (3 trials), "Lymphoma" (3 trials), "Peanut Allergy" (3 trials), "Diabetic Macular Edema" (2 trials) and "Diffuse Large B Cell Lymphoma" (2 trials). Many other conditions were trialed in "James Paget University Hospital" in a lesser frequency.

Most popular intervention types in "James Paget University Hospital" are "Drug" (26 trials), "Biological" (8 trials), "Other" (8 trials), "Procedure" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "cyclophosphamide" (3 trials), "AR101 powder provided in capsules & sachets" (2 trials), "Faricimab" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "James Paget University Hospital" are 37 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "James Paget University Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 24 completed trials in James Paget University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in James Paget University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".